COVID-19 mRNA vaccine approvals: key lessons for cell & gene therapy and mRNA therapeutic development

Published: 27 July 2021
Innovator Insight
Joseph Barberio,
Joseph Barberio
Director, mRNA Process Development, Strand Therapeutics
Christoph Kröner,
Christoph Kröner
Director DNA Process Development & Cap Technology, BioNTech SE
Venkata Indurthi,
Venkata Indurthi
Vice President Research and Development, Aldevron
Scott Zobbi
Scott Zobbi
Senior Manager Business Development for Custom POROS Resins, Bioproduction Division, Thermo Fisher Scientific

Joseph Barberio

Director, mRNA Process Development, Strand Therapeutics

Christoph Kröner

Director DNA Process Development & Cap Technology, BioNTech SE

Venkata Indurthi

Vice President Research and Development, Aldevron

Scott Zobbi

Senior Manager Business Development for Custom POROS Resins, Bioproduction Division, Thermo Fisher Scientific

Please note all fields marked with an * are mandatory

View article

Already registered? Login

If you have any problem accessing our content, please email info@insights.bio